APBB1IP and central nervous system cancer: According to the combined results from the Oncomine and TCGA data, APBB1IP was highly expressed in KIRC, KIRP, STAD, sarcoma, as well as brain and CNS cancers compared to corresponding normal tissues, while it had lower expression levels in BLCA, BRCA, COAD, LUAD, LUSC, PAAD, PCCG, READ, liver cancer and leukemia.